TABLE 4.
Drug class | Drug | Inhibition zone diam (mm) (mean ± SD) |
Result | ||||||
---|---|---|---|---|---|---|---|---|---|
ATCC BAA-835 | AM01 | AM02 | AM03 | AM04 | AM05 | AM06 | |||
Quinolones | Ciprofloxacin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Resistance |
Ofloxacin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Resistance | |
Norfloxacin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Resistance | |
Sulfamethoxazole | 32.50 ± 7.00 | 36.50 ± 9.00 | 40.00 ± 6.53 | 26.50 ± 4.43 | 34.00 ± 4.90 | 25.50 ± 3.79 | 32.00 ± 5.42 | IE | |
Aminoglycosides | Gentamicin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Resistance |
Kanamycin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Resistance | |
Tetracyclines | Tigecycline | 33.00 ± 5.03 | 38.00 ± 5.66 | 34.00 ± 5.16 | 32.00 ± 4.32 | 36.00 ± 1.63 | 31.50 ± 5.26 | 34.00 ± 4.90 | IE |
β-Lactams | Penicillin | 30.00 ± 4.32 | 37.50 ± 10.11 | 38.00 ± 3.27 | 33.00 ± 4.24 | 34.50 ± 1.91 | 26.50 ± 1.00 | 40.50 ±5.51 | Sensitivity |
Cefoperazone | 44.50 ± 5.74 | 37.50 ± 10.12 | 49.00 ± 10.39 | 18.00 ± 6.73 | 47.00 ± 8.25 | 35.00 ± 14.09 | 51.00 ±2.58 | Sensitivity | |
Macrolides | Chloramphenicol | 44.50 ± 7.55 | 36.50 ± 10.75 | 30.50 ± 4.12 | 32.50 + 3.42 | 35.50 ± 3.42 | 28.50 ± 2.52 | 32.50 ± 3.42 | Sensitivity |
Others | Vancomycin | 0 | 0 | 9.50 ± 1.91 | 9 ± 1.15 | 0 | 0 | 0 | Resistance |
Teicoplanin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Resistance | |
Bacitracin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Resistance | |
Fosfomycin | 35.50 ± 4.43 | 29.00 ± 1.89 | 38.50 ± 3.00 | 32.00 ± 5.16 | 21.50 ± 3.00 | 19.50 ± 7.72 | 30.50 ± 1.91 | IE | |
Lincosamide | 36.50 ± 7.72 | 36.00 ± 2.31 | 0 | 0 | 43.50 ± 4.12 | 37.50 ± 3.00 | 37.50 ± 2.52 | Resistance/IE |
IE, evidence and diameter of inhibition were inadequate for determination.